Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTNF Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | -$1.11 | N/A | N/A | $0 |
| 06/28/2024 | Q2 2024 | N/A | -$4.54 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$4.58 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$1.42 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | $2.70 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$3.10 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$1.14 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$2.85 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | -$2.84 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | -$2.85 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | -$3.24 | N/A | N/A | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$2.58 | N/A | N/A | $0 |
| 09/28/2021 | Q3 2021 | N/A | -$4.36 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$15.12 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$2.50 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | -$2.62 | N/A | N/A | $0 |
| 06/30/2020 | Q2 2020 | N/A | -$1.17 | N/A | N/A | $0 |
| 03/31/2020 | Q1 2020 | N/A | -$2.86 | N/A | N/A | $0 |
| 12/30/2019 | Q4 2019 | N/A | -$93.01 | N/A | N/A | $79,585 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TNF Pharmaceuticals, Inc. Earnings: FAQ's
TNF Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based offlast year's report dates.
The conference call for TNF Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for TNF Pharmaceuticals, Inc.'s latest earnings report can be read online.
TNF Pharmaceuticals, Inc. (:TNFA) has a recorded net income of $-3,999,950.TNF Pharmaceuticals, Inc. has generated $-5.33 earnings per share over the last four quarters.
TNF Pharmaceuticals, Inc. (:TNFA) has a price-to-earnings ratio of -0.04 and price/earnings-to-growth ratio is 0.